Institutes of Health and with the Guide for the Care and Use of Laboratory Animals (Institute of 23 Laboratory Animal Resources, National Academy of Sciences, Bethesda, Md) and were 24 approved by the institutional Animal Care and Use Committee (IACUC 666, approval date 25 02/19/2015 , authorization 96/2015 -PR and IACUC 709, approval date 08/31/2015 , 26 authorization 221/2015 . 27
Before all surgical and perfusion procedures, mice were anesthetized with an 28 intraperitoneal injection of 10 mg/kg xylazine (Intervet Farmaceutici, Milan, Italy) and 100 29 days after surgical procedure, acetaminophen 1mg/ml was administrated in drinking water 31 as analgesic drug. Fresh solution was prepared every 3 days for maximum efficacy. 32
For ANTI-210 experiments, 8-12 weeks old C57BL/6N male mice (Charles River 33 laboratories, Calco (Lecco), Italy) were used. For transgenic mouse experiments of hindlimb 34 ischemia, 8-12 weeks old doxycycline inducible transgenic C57BL/6NTac-35 Gt(ROSA)26Sor tm3720(Mir210)Tac (Tg210, Taconic Artemis, Germany) male mice and Wild Type 36 littermate (WT) were used. The generation of Tg210 mice has been previously described in 37 detail 1 . Briefly, the miR-210 coding region was inserted into the ROSA26 locus by using a 38 targeting strategy that allows doxycycline inducible overexpression of miR-210. 39 Acute hindlimb ischemia was induced by removing the femoral artery, as previously 40 described 2 . 41
Myocardial infarction was induced by coronary artery ligation in 8-12 weeks old Tg210, 42 female mice and WT littermate under anesthesia and mechanically ventilated. Briefly, 43 thoracotomy was performed via the third left-intercostal space and the left coronary artery 44 was ligated. The chest was closed and the mice were allowed to recover. Sham-operated 45 mice underwent a similar surgical procedure, except that the ligature around the coronary 46 artery was not tied. Animals were euthanized 1 month after surgery. 47
All mice were housed in groups of three to five at 22°±2 C using a 12 h light-12 h dark 48 cycle. Unless otherwise stated, animals were fed normal chow diet (SDS, irradiate VRF1). 49
For miR-210 induction, WT and Tg210 mice were fed with pellets of food containing 50 Doxycycline (Mucedola, Settimo Milanese (MI) Italy, NFM18 diet added with doxycycline 51 hyclate 2000 mg/kg). Doxycycline was administrated to WT littermate too, in order to 52 exclude side effects of the drug. The effectiveness of miR-210 induction was assessed by 53 qPCR on quadriceps femoris muscles or liver samples of each mouse analyzed. 54
Inhibition of miR-210 in vivo 55
In vivo down modulation of miR-210 was carried out by intraperitoneal injection of LNA 56 oligonucleotides against miR-210 (ANTI-210) or a scrambled control sequence (SCR) (In 57 vivo LNAmicroRNA Inhibitors; Exiqon, Vedbaek, Denmark). The following 15mers LNA-GCTGTCACACGCACA; SCR, CGTCTAGCCACCTAG. WT mice underwent hind limb 60 ischemia (day 0) and then they were randomized in two groups. After 5 days of ischemia, is determined using the Vevo LAB analysis software (FIJIFILM VisualSonics Inc., Toronto, 83 ON, Canada) that calculate the percentage of pixels which have a Power Doppler signal 84 associated with them. Residual calf perfusion was expressed as vascularity ratio (left 85 ischemic/right non ischemic). 86 oxygen and maintained at 0,5-1% isoflurane with oxygen during imaging at a rate of 88 1liter/minute, administered via nose cone. Anesthetized mice were positioned supine on a 89 heated imaging platform (THM150 MousePad part of the VisualSonics Vevo Integrated Rail 90 System III) and legs taped to electrocardiograph (ECG) leads to monitor heart and 91 respiration rates. Body temperature was monitored with a rectal probe. A depilatory cream 92 (Veet, Reckitt Benkiser, Milan, Italy) was used to remove fur from the anterior thorax and 93 prewarmed ultrasound gel (Aquasonic, Parker Laboratories Inc., Fairfield, NJ, USA) was 94 used as a coupling agent between the ultrasound probe and the skin. The probe was held in 95 position by a clamp mounted on the Vevo Rail System to avoid any compression of the 96 thorax and any small movement of the probe. During the acquisition the temperature of the 97 animal was maintained between 37°±1 C and the administration of the anesthetic was 98 adjusted to maintain the heart rate of the animal from 500 to 580 bpm. 99
All image acquisitions and offline measurements were conducted by a single experienced 100 operator who was blinded to animal groups. Frame rate of >200 frames per minute was 101 maintained for all B-mode and M-mode images. M-mode short-axis images were recorded 102 at the level of the papillary muscles and the LV was bisected to obtain an optimal M-mode 103 selection. For the analysis of M -mode Images, the Vevo LAB analysis software (Fujifilm 104 VisualSonics Inc., Toronto, ON, Canada) was used. Conventional echocardiographic 105 measurements of the LV included Ejection Fraction (EF), Fractional shortening (FS), end-106 diastolic dimension (EDD), end-systolic dimension (ESD), anterior and posterior wall 107 thickness, and mass. 108
Matrigel plug assay 109
The in vivo angiogenic Matrigel assay was performed as previously described 3 . Eight-ten 110 weeks old C57Bl/6N male mice were treated with ANTI-210 or SCR 12 mg/kg 2 days before 111
Matrigel injection (day -2). Next, 500 µl of Matrigel™ Basement Membrane Matrix 112 (CULTREX, Trevigen, Helgerman Court, Gaithersburg, MD 20877 USA) were loaded with 113 pro-angiogenic factors (200 ng/ml VEGF, 1 mg/ml FGF2 and 0.1 mg/ml Heparin) and 114 injected subcutaneously along the abdominal midline. Seven days after the first injection Two days later, at 7 days from Matrigel injection, mice were sacrificed and Matrigel plugs 117 were carefully dissected, formalin fixed and processed for paraffin inclusion and sectioning. 118
To analyze the efficacy of ANTI-210 treatment, skin and adductor muscles were snap-frozen 119 for RNA extraction and miRNA quantification by qPCR. 120
Genotyping analysis 121
Genomic DNA was extracted from tail biopsies. Tails were incubated with proteinase K 122 was amplified as a control and to determine the zygosity of the locus, using the following 130 primers: forward primer 5'-CTCTTCCCTCGTGATCTGCAACTCC-3' and reverse primer 131 5'CATGTCTTTAATCTACCTCGATGG-3'. PCR conditions were as follows: pre-132 denaturation at 95°C for 5 min, followed by denaturation at 95°C for 30 s, primer annealing 133 at 60°C for 30 s, and extension at 72°C for 1 min (35 cycles), and finally an additional 134 extension at 72°C for 10 min 1 . Genomic DNA samples from founder TG-210 mice and from 135 WT mice were used as positive and negative controls, respectively, in each PCR reaction. 136
The reaction was analyzed on 1.5% agarose gels containing ethidium bromide. 137
Sample preparation 138
For RNA extraction, muscles were snap frozen in liquid nitrogen. For histological analysis 139 of ischemic muscles, mice underwent euthanasia by overdose of anaesthesia and were 140 perfused with PBS pH 7.5, followed by 10% buffered formalin, at 100 mm/Hg for 10 min 2 . 141
The perfusion was carried out via left ventricle for gastrocnemius muscle harvesting and via 142 abdominal aorta for heart harvesting. Next, samples were harvested, fixed and paraffin paraffin inclusion and sectioning. 145
146
Tables 147   Table S1 148
The primers listed below were used for qPCR analysis: 149 hindlimb ischemia (day 0) and, at day 5, were randomized into two groups for further 168 treatments. In one of the groups, miR-210 function was blocked by systemic administration 169 of ANTI-210; the second group received a SCR sequence and was used as control. In both 170 groups, the angiogenic response was analyzed 2 and 7 days later (at 7 and 14 days of 171 ischemia respectively) by power Doppler and histological analysis. B. Gain of function: 172 schematic representation of miR-210 overexpression. WT and Tg210 untreated mice (UT) 173 underwent surgery at time 0. After 4 days and until the end of the study, both groups were 174 fed with pellets of food containing doxycycline to induce miR-210 over-expression 175 (Tg210 Doxy ) or as control (WT Doxy ). The angiogenic response was analyzed 3 days later (at 7 176 days of ischemia) by power Doppler and histological analysis. 177
Figure S4 178
Effective miR-210 inhibition and overexpression in vivo. A. The bar graph shows miR-179 210 levels measured in ischemic quadriceps femoris muscles by qPCR and expressed as fold 180 change versus the SCR controls, after 2 or 7 days of treatment (n=6-8, Two way Anova 181 #P<0.0001). B. The bar graph shows miR-210 levels measured in non-ischemic 182 gastrocnemius muscles by qPCR and expressed as fold induction versus WT controls, after 183 doxycycline administration (n=3-9; Anova multiple comparison #P=0.0001). 
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